Final results of a phase II study of Taxotere (docetaxel, D), doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in the treatment of metastatic breast cancer (MBC)

被引：0
|
作者：
Nabholtz, JM [1 ]
Mackey, JR [1 ]
Smylie, M [1 ]
Paterson, A [1 ]
Noel, D [1 ]
Al-Twelgeri, T [1 ]
Janowska-Wieczorek, A [1 ]
Delome, F [1 ]
Riva, A [1 ]
机构：
[1] Cross Canc Inst, Dept Med, Edmonton, AB T6G 1Z2, Canada
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(98)80164-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
173
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Phase II study of taxotere(R) (docetaxel, D), Doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in the treatment of metastatic breast cancer (MBC)
    Nabholtz, JM
    Mackey, JR
    Smylie, M
    Paterson, A
    Noel, D
    AlTweigeri, T
    Delorme, F
    [J]. BREAST, 1997, 6 (05): : P953 - P953
  • [2] Taxotere(TM) (docetaxel, D), doxorubicin (Dx) and cyclophosphamide (CTX) (TAC) in the treatment of metastatic breast cancer (MBC)
    Nabholtz, JM
    Smyllo, M
    Mackey, JR
    Paterson, A
    Noel, D
    AlTwelgerl, T
    Au, D
    Sansregret, E
    Delorme, F
    Riva, A
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 : 650 - 650
  • [3] Sequential treatment with doxorubicin and docetaxel as first-line chemotherapy in metastatic breast cancer (MBC).: Final results of a Phase II GEICAM study
    Alba, E
    Antón, A
    Ribelles, N
    Pérez-Carrión, R
    López-Vega, J
    Llanos, M
    Pelegri, A
    Florián, J
    Menéndez, M
    Godés, M
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S66 - S66
  • [4] Sequential treatment of docetaxel plus doxorubicin/cyclophosphamide (AC) as first-line chemotherapy for metastatic breast cancer (MBC).: Final results and survival analysis of a phase II study
    Antón, A
    Colomer, R
    Lluch, A
    Massuti, B
    Corral, M
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S68 - S69
  • [5] Docetaxel with epirubicin as first line chemotherapy in metastatic breast cancer (MBC).: Final results of a Phase II study
    Morales, S
    Lorenzo, A
    Ramos, M
    Ballesteros, P
    Méndez, M
    Almanza, C
    Moreno-Nogueira, J
    Casal, J
    Castellanos, J
    Lizón, J
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S68 - S68
  • [6] Taxotere® (T) and doxorubicin (D) combination:: A phase II South American study in first line treatment (tt) of metastatic breast cancer (MBC)
    Vallejos, C
    Nunez, P
    Orlandi, L
    Carranza, H
    Fodor, M
    Reyes, JM
    Majlis, A
    Gavilanes, P
    Boussard, B
    Salas, E
    [J]. EUROPEAN JOURNAL OF CANCER, 1999, 35 : S329 - S329
  • [7] Phase Ib study of eribulin (ERB) and cyclophosphamide (CTX) in metastatic breast cancer (MBC).
    Truong, Thach-Giao
    Pelayo, Michael
    Grabowsky, Jennifer A.
    Melisko, Michelle E.
    Magbanua, Mark Jesus Mendoza
    Moasser, Mark M.
    Reinert, Anne
    Hwang, Jimmy
    Park, John W.
    Munster, Pamela N.
    Rugo, Hope S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (26)
  • [8] Phase Ib study of eribulin (ERB) and cyclophosphamide (CTX) in metastatic breast cancer (MBC)
    Thach-Giao Truong
    Pelayo, Michael
    Grabowsky, Jennifer A.
    Melisko, Michelle E.
    Magbanua, Mark Jesus Mendoza
    Moasser, Mark M.
    Reinert, Anne
    Hwang, Jimmy
    Park, John W.
    Munster, Pamela N.
    Rugo, Hope S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [9] A phase II study of, Docetaxel (T), Doxorubicin (A) and Cyclophosphamide (C)-TAC, in metastatic breast cancer - experience on 139 cases from Bangladesh
    Karim, A. B. M. F.
    Alam, A. M. M. Shariful
    Akhtar, P. S.
    Banu, P. A.
    Hai, M. A.
    Reza, M. S.
    Chowdhury, Q.
    Hoque, E.
    Ahmed, T. U.
    [J]. EJC SUPPLEMENTS, 2008, 6 (07): : 178 - 178
  • [10] A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer
    Perez, EA
    Geeraerts, L
    Suman, VJ
    Adjei, AA
    Baron, AT
    Hatfield, AK
    Maihle, N
    Michalak, JC
    Kuross, SA
    Kugler, JW
    Lafky, JM
    Ingle, JN
    [J]. ANNALS OF ONCOLOGY, 2002, 13 (08) : 1225 - 1235
12345